Breast Cancer Highlights From ASCO 2026: ADCs, Biomarkers, and Earlier Treatment Strategies Take Center Stage
Amol Akhade: What The Devil Wears Prada 2 Taught Me About Oncology?
Alexandre Chan: Real-World Safety of Antibody–Drug Conjugates
Christopher Jackson: If Innovation Is the Heart of Oncology, Then Access Must Be Its Conscience
IMMUNIB Study Uptades: Nivolumab Plus Lenvatinib in Unresectable HCC
Khizra Ahmad: Covering ASCO26 from Front-Row Seat as OncoDaily Ambassador
Hesham ElGhazaly: Meeting Global Oncology Leaders at ASCO 2026
ESTRO-EORTC Expert Guideline on Target Delineation and Radiotherapy for Stage I–III Small Cell Lung Cancer
The POC NOW 2025 will be held at March 18, 2025 at New York, US. The POC NOW 2025 Summit gathers healthcare marketers, pharmaceutical decision-makers, agency leaders, and Point of […]
